Rani Therapeutics Ownership | Who Owns Rani Therapeutics?

Overview ForecastFinancials Chart Transcripts

Rani Therapeutics Ownership Summary

Rani Therapeutics is owned by 13.24% institutional investors, 27.31% insiders, and 59.44% retail investors. Vanguard group is the largest institutional shareholder, holding 2.46% of RANI shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.56% of its assets in Rani Therapeutics shares.

RANI Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Rani Therapeutics	13.24%	27.31%	59.44%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	709.83K	2.46%	$972.47K
Nan fung group	493.58K	1.71%	$676.21K
Alphabet	448.49K	1.56%	$614.43K
United services automobile association	302.74K	1.05%	$414.76K
Two sigma investments, lp	291.38K	1.01%	$399.19K
Takeda pharmaceutical	203.19K	0.70%	$278.37K
Geode capital management	171.57K	0.59%	$235.11K
Kestra private wealth services	119.62K	0.41%	$163.88K
Two sigma advisers, lp	110.16K	0.38%	$150.92K
Bank of america corp /de/	91.85K	0.35%	$349.01K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Takeda pharmaceutical	203.19K	1.05%	$278.37K
Nan fung group	493.58K	0.58%	$676.21K
Lasry marc	62.89K	0.38%	$86.16K
Alphabet	448.49K	0.04%	$614.43K
Ground swell capital	17.15K	0.04%	$23.50K
United services automobile association	302.74K	0.01%	$414.76K
Islay capital management	9.61K	0.01%	$13.17K
Motco	48.13K	0.01%	$65.94K
Insigneo advisory services	47.50K	0.01%	$65.08K
Lafayette investments	19.89K	0.01%	$27.25K

Top Buyers

Holder	Shares	% Assets	Change
Two sigma investments, lp	291.38K	0.00%	291.38K
Kestra private wealth services	119.62K	0.00%	119.62K
Two sigma advisers, lp	110.16K	0.00%	110.16K
Insigneo advisory services	47.50K	0.01%	47.50K
Virtu financial	45.40K	0.00%	45.40K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-2.57M
Stifel financial	14.68K	-	-255.08K
King luther capital management	33.00K	0.00%	-48.13K
Alpha square group s	-	-	-33.40K
Renaissance	-	-	-33.20K

New Positions

Holder	Shares	% Assets	Change	Value
Two sigma investments, lp	291.38K	0.00%	291.38K	$399.19K
Kestra private wealth services	119.62K	0.00%	119.62K	$163.88K
Two sigma advisers, lp	110.16K	0.00%	110.16K	$150.92K
Insigneo advisory services	47.50K	0.01%	47.50K	$65.08K
Ground swell capital	17.15K	0.04%	17.15K	$23.50K

Sold Out

Holder	Change
Qube research	-3.00
Wells fargo & company/mn	-103.00
Belvedere trading	-991.00
Tower research capital llc (trc)	-1.72K
Simplex trading	-2.83K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	44	33.33%	3,818,467	-35.40%	13	3.15%	21	61.54%	5	-
Sep 30, 2024	32	-11.11%	5,707,881	97.28%	19	16.03%	13	8.33%	4	-42.86%
Jun 30, 2024	36	-2.70%	2,893,303	-7.12%	11	7.45%	12	-	7	40.00%
Mar 31, 2024	37	15.63%	3,115,105	5.54%	12	9.15%	12	140.00%	5	-16.67%
Dec 31, 2023	32	-3.03%	2,951,624	-8.01%	11	7.21%	5	-44.44%	6	-14.29%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	518.70K	1.56%	-
Vanguard Institutional Extnd Mkt Idx Tr	172.98K	0.52%	-
Tema Obesity & Cardiometabolic ETF	105.60K	0.32%	-
Fidelity Extended Market Index	85.70K	0.26%	-546.00
Bridgeway Ultra-Small Company Market	56.50K	0.17%	-15.00K
Fidelity Total Market Index	26.09K	0.08%	-
Northern Small Cap Core I	23.70K	0.07%	-
Fidelity Series Total Market Index	21.34K	0.06%	1.02K
BlackRock Extended Equity Market K	16.40K	0.06%	-7.00
Northern Trust Extended Eq Market Idx	16.26K	0.05%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 13, 2024	McKinley Kate	Chief Business Officer	Buy	$29.99K
Dec 09, 2024	Imran Talat	Chief Executive Officer	Buy	$19.97K
Oct 15, 2024	South Cone Investments Limited Partnership	-	Sell	$1.71M
Oct 15, 2024	South Cone Investments Limited Partnership	-	Sell	$8.44M
Nov 24, 2023	Quiroga Cortes Isidoro Alfonso	-	Sell	$10.58M

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	2	2
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	8	1
2023 Q3	-	-

RANI Ownership FAQ

Who Owns Rani Therapeutics?

Rani Therapeutics shareholders are primarily institutional investors at 13.24%, followed by 27.31% insiders and 59.45% retail investors. The average institutional ownership in Rani Therapeutics's industry, Biotech Stocks , is 68.48%, which Rani Therapeutics falls below.

Who owns the most shares of Rani Therapeutics?

Rani Therapeutics’s largest shareholders are Vanguard group (709.83K shares, 2.46%), Nan fung group (493.58K shares, 1.71%), and Alphabet (448.49K shares, 1.56%). Together, they hold 5.73% of Rani Therapeutics’s total shares outstanding.

Does Blackrock own Rani Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Rani Therapeutics.

Who is Rani Therapeutics’s biggest shareholder by percentage of total assets invested?

Takeda pharmaceutical is Rani Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.05% of its assets in 203.19K Rani Therapeutics shares, valued at 278.37K$.

Who is the top mutual fund holder of Rani Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Rani Therapeutics shares, with 1.56% of its total shares outstanding invested in 518.7K Rani Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools